These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29325751)

  • 1. A difficult diagnosis of coeliac disease: Repeat duodenal histology increases diagnostic yield in patients with concomitant causes of villous atrophy.
    Morreale GC; Montalbano LM; Cappello M; Sinagra E; Rizzo A; Carroccio A
    Arab J Gastroenterol; 2017 Dec; 18(4):241-244. PubMed ID: 29325751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The significance of duodenal mucosal atrophy in patients with common variable immunodeficiency: a clinical and histopathologic study.
    Biagi F; Bianchi PI; Zilli A; Marchese A; Luinetti O; Lougaris V; Plebani A; Villanacci V; Corazza GR
    Am J Clin Pathol; 2012 Aug; 138(2):185-9. PubMed ID: 22904128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving basic skills in celiac-like disease diagnosis: a case report.
    Corleto VD; Di Marino VP; Galli G; Antonelli G; Coluccio C; Di Cerbo A; Uccini S; Annibale B
    BMC Gastroenterol; 2018 Nov; 18(1):162. PubMed ID: 30390626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum anti-tissue transglutaminase IgA and prediction of duodenal villous atrophy in adults with suspected coeliac disease without IgA deficiency (Bi.A.CeD): a multicentre, prospective cohort study.
    Ciacci C; Bai JC; Holmes G; Al-Toma A; Biagi F; Carroccio A; Ciccocioppo R; Di Sabatino A; Gingold-Belfer R; Jinga M; Makharia G; Niveloni S; Norman GL; Rostami K; Sanders DS; Smecuol E; Villanacci V; Vivas S; Zingone F;
    Lancet Gastroenterol Hepatol; 2023 Nov; 8(11):1005-1014. PubMed ID: 37696284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis.
    Silvester JA; Kurada S; Szwajcer A; Kelly CP; Leffler DA; Duerksen DR
    Gastroenterology; 2017 Sep; 153(3):689-701.e1. PubMed ID: 28545781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short article: Mortality and differential diagnoses of villous atrophy without coeliac antibodies.
    Schiepatti A; Biagi F; Fraternale G; Vattiato C; Balduzzi D; Agazzi S; Alpini C; Klersy C; Corazza GR
    Eur J Gastroenterol Hepatol; 2017 May; 29(5):572-576. PubMed ID: 28350748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The high mortality of patients with common variable immunodeficiency and small bowel villous atrophy.
    Pensieri MV; Pulvirenti F; Schiepatti A; Maimaris S; Lattanzio S; Quinti I; Klersy C; Corazza GR; Biagi F
    Scand J Gastroenterol; 2019 Feb; 54(2):164-168. PubMed ID: 31006294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Predictive value of serological tests in the diagnosis of celiac disease].
    Carroccio A; Di Prima L; Falci C; Le Moli C; Soresi M; Montalto G; Notarbartolo A
    Ann Ital Med Int; 2002; 17(2):102-7. PubMed ID: 12150043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncoeliac enteropathy: the differential diagnosis of villous atrophy in contemporary clinical practice.
    Pallav K; Leffler DA; Tariq S; Kabbani T; Hansen J; Peer A; Bhansali A; Najarian R; Kelly CP
    Aliment Pharmacol Ther; 2012 Feb; 35(3):380-90. PubMed ID: 22145590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seronegative Celiac Disease and Immunoglobulin Deficiency: Where to Look in the Submerged Iceberg?
    Giorgio F; Principi M; Losurdo G; Piscitelli D; Iannone A; Barone M; Amoruso A; Ierardi E; Di Leo A
    Nutrients; 2015 Sep; 7(9):7486-504. PubMed ID: 26371035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the role of serologic testing in celiac disease? A prospective, biopsy-confirmed study with economic analysis.
    Hopper AD; Hadjivassiliou M; Hurlstone DP; Lobo AJ; McAlindon ME; Egner W; Wild G; Sanders DS
    Clin Gastroenterol Hepatol; 2008 Mar; 6(3):314-20. PubMed ID: 18328437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies.
    Adriaanse MP; Tack GJ; Passos VL; Damoiseaux JG; Schreurs MW; van Wijck K; Riedl RG; Masclee AA; Buurman WA; Mulder CJ; Vreugdenhil AC
    Aliment Pharmacol Ther; 2013 Feb; 37(4):482-90. PubMed ID: 23289539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of the organ culture system when villous height/crypt depth ratio, intraepithelial lymphocyte count, or serum antibody tests are not diagnostic for celiac disease.
    Picarelli A; Di Tola M; Marino M; Libanori V; Borghini R; Salvi E; Donato G; Vitolo D; Tiberti A; Marcheggiano A; Bassotti G; Corazziari E
    Transl Res; 2013 Mar; 161(3):172-80. PubMed ID: 23177794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coeliac disease.
    Glissen Brown JR; Singh P
    Paediatr Int Child Health; 2019 Feb; 39(1):23-31. PubMed ID: 30099930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the anti-endomysial antibody test to diagnose coeliac disease in clinical practice.
    Pearce AB; Sinclair D; Duncan HD; Saas M; Poller DN
    Clin Lab; 2002; 48(5-6):319-25. PubMed ID: 12071583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgA class anti-endomysial and anti-tissue transglutaminase antibodies in relation to duodenal mucosa changes in coeliac disease.
    Kotze LM; Utiyama SR; Nisihara RM; de Camargo VF; Ioshii SO
    Pathology; 2003 Feb; 35(1):56-60. PubMed ID: 12701686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High tissue-transglutaminase antibody level predicts small intestinal villous atrophy in adult patients at high risk of celiac disease.
    Zanini B; Magni A; Caselani F; Lanzarotto F; Carabellese N; Villanacci V; Ricci C; Lanzini A
    Dig Liver Dis; 2012 Apr; 44(4):280-5. PubMed ID: 22119616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiendomysium antibodies assay in the culture medium of intestinal mucosa: an accurate method for celiac disease diagnosis.
    Carroccio A; Iacono G; Di Prima L; Pirrone G; Cavataio F; Ambrosiano G; Sciumè C; Geraci G; Florena A; Teresi S; Barbaria F; Pepe I; Campisi G; Mansueto P; Soresi M; Di Fede G
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(11):1018-23. PubMed ID: 21885984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic significance of HLA-DQ typing in patients with previous coeliac disease diagnosis based on histology alone.
    Kapitány A; Tóth L; Tumpek J; Csípo I; Sipos E; Woolley N; Partanen J; Szegedi G; Oláh E; Sipka S; Korponay-Szabó IR
    Aliment Pharmacol Ther; 2006 Nov; 24(9):1395-402. PubMed ID: 17059521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of an IgA/IgG-Deamidated Gliadin Peptide Point-of-Care Test in Predicting Persistent Villous Atrophy in Patients With Celiac Disease on a Gluten-Free Diet.
    Lau MS; Mooney PD; White WL; Rees MA; Wong SH; Kurien M; Trott N; Leffler DA; Hadjivassiliou M; Sanders DS
    Am J Gastroenterol; 2017 Dec; 112(12):1859-1867. PubMed ID: 29016564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.